• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

多奈哌齐治疗阿尔茨海默病对皮质乙酰胆碱酯酶活性的抑制程度及认知效应

Degree of inhibition of cortical acetylcholinesterase activity and cognitive effects by donepezil treatment in Alzheimer's disease.

作者信息

Bohnen N I, Kaufer D I, Hendrickson R, Ivanco L S, Lopresti B J, Koeppe R A, Meltzer C C, Constantine G, Davis J G, Mathis C A, Dekosky S T, Moore R Y

机构信息

University of Pittsburgh, Liliane S Kaufmann Building, Suite 811, 3471 Fifth Avenue, Pittsburgh, PA 15213, USA.

出版信息

J Neurol Neurosurg Psychiatry. 2005 Mar;76(3):315-9. doi: 10.1136/jnnp.2004.038729.

DOI:10.1136/jnnp.2004.038729
PMID:15716518
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1739536/
Abstract

OBJECTIVES

To determine in vivo cortical acetylcholinesterase (AChE) activity and cognitive effects in subjects with mild Alzheimer's disease (AD, n = 14) prior to and after 12 weeks of donepezil therapy.

METHODS

Cognitive and N-[(11)C]methyl-piperidin-4-yl propionate ([(11)C]PMP) AChE positron emission tomography (PET) assessments before and after donepezil therapy.

RESULTS

Analysis of the PET data revealed mean (temporal, parietal, and frontal) cortical donepezil induced AChE inhibition of 19.1% (SD 9.4%) (t = -7.9; p<0.0001). Enzyme inhibition was most robust in the anterior cingulate cortex (24.2% (6.9%), t = -14.1; p<0.0001). Donepezil induced cortical inhibition of AChE activity correlated with changes in the Stroop Color Word interference scores (R(2) = 0.59, p<0.01), but not with primary memory test scores. Analysis of the Stroop test data indicated that subjects with AChE inhibition greater than the median value (>22.2%) had improved scores on the Stroop Color Word Test compared with subjects with less inhibition who had stable to worsening scores (t = -2.7; p<0.05).

CONCLUSIONS

Donepezil induced inhibition of cortical AChE enzyme activity is modest in patients with mild AD. The degree of cortical enzyme inhibition correlates with changes in executive and attentional functions.

摘要

目的

确定轻度阿尔茨海默病(AD,n = 14)患者在多奈哌齐治疗12周前后的体内皮质乙酰胆碱酯酶(AChE)活性及认知效应。

方法

在多奈哌齐治疗前后进行认知和N-[(11)C]甲基-哌啶-4-基丙酸酯([(11)C]PMP)AChE正电子发射断层扫描(PET)评估。

结果

PET数据分析显示,多奈哌齐诱导的平均(颞叶、顶叶和额叶)皮质AChE抑制率为19.1%(标准差9.4%)(t = -7.9;p<0.0001)。在前扣带回皮质中酶抑制作用最强(24.2%(6.9%),t = -14.1;p<0.0001)。多奈哌齐诱导的皮质AChE活性抑制与Stroop颜色词干扰分数的变化相关(R(2) = 0.59,p<0.01),但与初级记忆测试分数无关。Stroop测试数据分析表明,AChE抑制大于中位数(>22.2%)的受试者在Stroop颜色词测试中的分数有所改善,而抑制较少的受试者分数稳定或恶化(t = -2.7;p<0.05)。

结论

在轻度AD患者中,多奈哌齐诱导的皮质AChE酶活性抑制作用较小。皮质酶抑制程度与执行和注意力功能的变化相关。

相似文献

1
Degree of inhibition of cortical acetylcholinesterase activity and cognitive effects by donepezil treatment in Alzheimer's disease.多奈哌齐治疗阿尔茨海默病对皮质乙酰胆碱酯酶活性的抑制程度及认知效应
J Neurol Neurosurg Psychiatry. 2005 Mar;76(3):315-9. doi: 10.1136/jnnp.2004.038729.
2
Regional effects of donepezil and rivastigmine on cortical acetylcholinesterase activity in Alzheimer's disease.多奈哌齐和卡巴拉汀对阿尔茨海默病患者皮质乙酰胆碱酯酶活性的区域影响。
J Clin Psychopharmacol. 2002 Dec;22(6):615-20. doi: 10.1097/00004714-200212000-00012.
3
Estimation of plasma IC50 of donepezil for cerebral acetylcholinesterase inhibition in patients with Alzheimer disease using positron emission tomography.使用正电子发射断层扫描技术评估多奈哌齐对阿尔茨海默病患者脑内乙酰胆碱酯酶抑制作用的血浆半数抑制浓度(IC50)
Clin Neuropharmacol. 2010 Mar-Apr;33(2):74-8. doi: 10.1097/WNF.0b013e3181c71be9.
4
The efficacy of donepezil administration on acetylcholinesterase activity and altered redox homeostasis in Alzheimer's disease.多奈哌齐给药对阿尔茨海默病乙酰胆碱酯酶活性和氧化还原失衡的影响。
Biomed Pharmacother. 2017 Jun;90:786-795. doi: 10.1016/j.biopha.2017.03.101. Epub 2017 Apr 18.
5
Estimation of plasma IC50 of donepezil hydrochloride for brain acetylcholinesterase inhibition in monkey using N-[11C]methylpiperidin-4-yl acetate ([11C]MP4A) and PET.使用N-[11C]甲基哌啶-4-基乙酸酯([11C]MP4A)和正电子发射断层扫描(PET)估算盐酸多奈哌齐对猴子脑乙酰胆碱酯酶抑制作用的血浆半数抑制浓度(IC50)
Neuropsychopharmacology. 2005 Dec;30(12):2154-61. doi: 10.1038/sj.npp.1300759.
6
[Pre-clinical evaluation of effects of acetylcholinesterase inhibition on the cerebral cholinergic neuronal system and cognitive function: PET study in conscious monkeys].[乙酰胆碱酯酶抑制对大脑胆碱能神经元系统及认知功能影响的临床前评估:清醒猴子的正电子发射断层扫描研究]
Nihon Yakurigaku Zasshi. 2004 Sep;124(3):153-61. doi: 10.1254/fpj.124.153.
7
Changes in the activity and protein levels of CSF acetylcholinesterases in relation to cognitive function of patients with mild Alzheimer's disease following chronic donepezil treatment.慢性多奈哌齐治疗后轻度阿尔茨海默病患者脑脊液乙酰胆碱酯酶活性和蛋白水平变化与认知功能的关系
J Neural Transm (Vienna). 2006 Nov;113(11):1791-801. doi: 10.1007/s00702-006-0526-2. Epub 2006 Aug 1.
8
Limited donepezil inhibition of acetylcholinesterase measured with positron emission tomography in living Alzheimer cerebral cortex.在活体阿尔茨海默病大脑皮层中,用正电子发射断层扫描测量的多奈哌齐对乙酰胆碱酯酶的抑制作用有限。
Ann Neurol. 2000 Sep;48(3):391-5.
9
Cognitive correlates of cortical cholinergic denervation in Parkinson's disease and parkinsonian dementia.帕金森病和帕金森病性痴呆中皮质胆碱能去神经支配的认知相关性。
J Neurol. 2006 Feb;253(2):242-7. doi: 10.1007/s00415-005-0971-0. Epub 2005 Sep 2.
10
Differential increase in cerebrospinal fluid-acetylcholinesterase after treatment with acetylcholinesterase inhibitors in patients with Alzheimer's disease.阿尔茨海默病患者使用乙酰胆碱酯酶抑制剂治疗后脑脊液中乙酰胆碱酯酶的差异增加。
Neurosci Lett. 2001 Mar 16;300(3):157-60. doi: 10.1016/s0304-3940(01)01586-5.

引用本文的文献

1
Investigating the impact of environmental enrichment on proteome and neurotransmitter-related profiles in an animal model of Alzheimer's disease.研究环境丰容对阿尔茨海默病动物模型中蛋白质组和神经递质相关特征的影响。
Aging Cell. 2024 Sep;23(9):e14231. doi: 10.1111/acel.14231. Epub 2024 Jul 1.
2
Long-Term Acetylcholinesterase Depletion Alters the Levels of Key Synaptic Proteins while Maintaining Neuronal Markers in the Aging Zebrafish (Danio rerio) Brain.长期乙酰胆碱酯酶耗竭会改变衰老斑马鱼(Danio rerio)大脑中关键突触蛋白的水平,同时保持神经元标志物。
Gerontology. 2023;69(12):1424-1436. doi: 10.1159/000534343. Epub 2023 Oct 4.
3
Deciphering the Role of Peroxisome Proliferator-activated Receptor α and Phosphodiesterase Type 5 Targets in Alzheimer's Disease.解析过氧化物酶体增殖物激活受体 α 和磷酸二酯酶 5 靶点在阿尔茨海默病中的作用。
CNS Neurol Disord Drug Targets. 2024;23(8):956-970. doi: 10.2174/1871527323666230904150841.
4
Central nervous system effects of TAK-653, an investigational alpha-amino-3-hydroxy-5-methyl-4-isoxazole receptor (AMPAR) positive allosteric modulator in healthy volunteers.健康志愿者中,一种新型的 alpha-氨基-3-羟基-5-甲基-4-异恶唑受体(AMPAR)正变构调节剂 TAK-653 的中枢神经系统作用。
Transl Psychiatry. 2022 Sep 24;12(1):408. doi: 10.1038/s41398-022-02148-w.
5
Cholinergic systems, attentional-motor integration, and cognitive control in Parkinson's disease.帕金森病中的胆碱能系统、注意-运动整合和认知控制。
Prog Brain Res. 2022;269(1):345-371. doi: 10.1016/bs.pbr.2022.01.011. Epub 2022 Feb 4.
6
Anti-Neurodegenerative Benefits of Acetylcholinesterase Inhibitors in Alzheimer's Disease: Nexus of Cholinergic and Nerve Growth Factor Dysfunction.乙酰胆碱酯酶抑制剂在阿尔茨海默病中的神经退行性保护作用:胆碱能和神经生长因子功能障碍的关系。
Curr Alzheimer Res. 2021;18(13):1010-1022. doi: 10.2174/1567205018666211215150547.
7
The Development of Pharmacological Therapies for Alzheimer's Disease.阿尔茨海默病药物治疗的发展
Neurol Ther. 2021 Dec;10(2):609-626. doi: 10.1007/s40120-021-00282-z. Epub 2021 Sep 16.
8
α4β2 Nicotinic Cholinergic Receptor Target Engagement in Parkinson Disease Gait-Balance Disorders.α4β2 型烟碱型乙酰胆碱受体在帕金森病步态-平衡障碍中的靶向作用
Ann Neurol. 2021 Jul;90(1):130-142. doi: 10.1002/ana.26102. Epub 2021 May 26.
9
Improving Anti-Neurodegenerative Benefits of Acetylcholinesterase Inhibitors in Alzheimer's Disease: Are Irreversible Inhibitors the Future?提高乙酰胆碱酯酶抑制剂在阿尔茨海默病中的神经退行性保护作用:不可逆抑制剂是未来的趋势吗?
Int J Mol Sci. 2020 May 13;21(10):3438. doi: 10.3390/ijms21103438.
10
Is Combining an Anticholinergic with a Cholinesterase Inhibitor a Good Strategy for High-Level CNS Cholinesterase Inhibition?将抗胆碱能药物与胆碱酯酶抑制剂联合用于高级中枢神经系统胆碱酯酶抑制是否是一种好策略?
J Alzheimers Dis. 2019;71(4):1099-1103. doi: 10.3233/JAD-190626.

本文引用的文献

1
Regional effects of donepezil and rivastigmine on cortical acetylcholinesterase activity in Alzheimer's disease.多奈哌齐和卡巴拉汀对阿尔茨海默病患者皮质乙酰胆碱酯酶活性的区域影响。
J Clin Psychopharmacol. 2002 Dec;22(6):615-20. doi: 10.1097/00004714-200212000-00012.
2
Clinical pharmacokinetics and pharmacodynamics of cholinesterase inhibitors.胆碱酯酶抑制剂的临床药代动力学和药效学
Clin Pharmacokinet. 2002;41(10):719-39. doi: 10.2165/00003088-200241100-00003.
3
PET imaging of brain acetylcholinesterase using [11C]CP-126,998, a brain selective enzyme inhibitor.使用脑选择性酶抑制剂[11C]CP - 126,998对脑乙酰胆碱酯酶进行正电子发射断层显像(PET)。
Synapse. 2002 Jul;45(1):1-9. doi: 10.1002/syn.10072.
4
Widely spread butyrylcholinesterase can hydrolyze acetylcholine in the normal and Alzheimer brain.广泛分布的丁酰胆碱酯酶可在正常大脑和阿尔茨海默病大脑中水解乙酰胆碱。
Neurobiol Dis. 2002 Feb;9(1):88-93. doi: 10.1006/nbdi.2001.0462.
5
Positron emission tomographic measurement of brain acetylcholinesterase activity using N-[(11)C]methylpiperidin-4-yl acetate without arterial blood sampling: methodology of shape analysis and its diagnostic power for Alzheimer's disease.使用N-[(11)C]甲基哌啶-4-基乙酸酯在无需采集动脉血的情况下进行正电子发射断层扫描测量脑乙酰胆碱酯酶活性:形状分析方法及其对阿尔茨海默病的诊断能力
J Cereb Blood Flow Metab. 2001 Mar;21(3):295-306. doi: 10.1097/00004647-200103000-00013.
6
Effect of donepezil on brain acetylcholinesterase activity in patients with AD measured by PET.通过正电子发射断层扫描(PET)测量多奈哌齐对阿尔茨海默病(AD)患者脑乙酰胆碱酯酶活性的影响。
Neurology. 2001 Feb 13;56(3):408-10. doi: 10.1212/wnl.56.3.408.
7
Orbital and dorsolateral frontal perfusion defect associated with behavioral response to cholinesterase inhibitor therapy in Alzheimer's disease.与阿尔茨海默病中胆碱酯酶抑制剂治疗的行为反应相关的眶额和背外侧额叶灌注缺损
J Neuropsychiatry Clin Neurosci. 2000 Spring;12(2):209-18. doi: 10.1176/jnp.12.2.209.
8
Limited donepezil inhibition of acetylcholinesterase measured with positron emission tomography in living Alzheimer cerebral cortex.在活体阿尔茨海默病大脑皮层中,用正电子发射断层扫描测量的多奈哌齐对乙酰胆碱酯酶的抑制作用有限。
Ann Neurol. 2000 Sep;48(3):391-5.
9
Changes in the rCBF images of patients with Alzheimer's disease receiving Donepezil therapy.接受多奈哌齐治疗的阿尔茨海默病患者的局部脑血流量图像变化。
Nucl Med Commun. 2000 Jan;21(1):37-41. doi: 10.1097/00006231-200001000-00007.
10
Cholinesterase inhibitors: A new class of psychotropic compounds.胆碱酯酶抑制剂:一类新型精神药物化合物。
Am J Psychiatry. 2000 Jan;157(1):4-15. doi: 10.1176/ajp.157.1.4.